RecallRadar

FDA Drug recall D-1288-2022

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Dis…

On 2022-08-03 the FDA classified a Class II recall of Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Dis… by Dr Reddy S Laboratories, citing FAILED DISSOLUTION SPECIFICATIONS.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1288-2022
ClassificationClass II
Statusterminated
Initiated2022-07-13
Published2022-08-03
Last updated2026-09-13 11:52 UTC
CompanyDr Reddy S Laboratories
DistributionUS

Product

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, blister barcode 4359856179, NDC 43598-561-78

Reason

FAILED DISSOLUTION SPECIFICATIONS

Identifiers

ndc43598-560-79
ndc43598-560-78
ndc43598-561-79
ndc43598-561-78
ndc4359856179
code_infoLot T2100515, Exp 01/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1288-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.